U.S. markets closed

U.S. Stem Cell, Inc. (USRM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0231+0.0002 (+0.87%)
At close: 3:54PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/13/2021
Current
Market Cap (intraday) 5
10.18M
Enterprise Value 3
16.37M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
2.19
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
3.70
Enterprise Value/EBITDA 7
-7.55

Trading Information

Stock Price History

Beta (5Y Monthly) 2.11
52-Week Change 3228.57%
S&P500 52-Week Change 341.30%
52 Week High 30.0870
52 Week Low 30.0030
50-Day Moving Average 30.0423
200-Day Moving Average 30.0317

Share Statistics

Avg Vol (3 month) 32.55M
Avg Vol (10 day) 34.11M
Shares Outstanding 5407.11M
Implied Shares Outstanding 6N/A
Float 373.77M
% Held by Insiders 17.95%
% Held by Institutions 10.00%
Shares Short (Feb 26, 2009) 4N/A
Short Ratio (Feb 26, 2009) 40
Short % of Float (Feb 26, 2009) 4N/A
Short % of Shares Outstanding (Feb 26, 2009) 40.00%
Shares Short (prior month Jan 29, 2009) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:1000
Last Split Date 3Nov 03, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -81.41%
Operating Margin (ttm)-46.93%

Management Effectiveness

Return on Assets (ttm)-95.37%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.43M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-89.60%
Gross Profit (ttm)4.59M
EBITDA -1.87M
Net Income Avi to Common (ttm)-3.6M
Diluted EPS (ttm)-0.0090
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)78.1k
Total Cash Per Share (mrq)0
Total Debt (mrq)6.65M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.02
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-965.91k
Levered Free Cash Flow (ttm)-1.02M